The proto-oncogene tyrosine protein kinase Src is essential for macrophage-myofibroblast transition during renal

Patrick Ming-Kuen Tang1, Shuang Zhou2, Chun-Jie Li3

  • 1Department of Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Hong Kong SAR, China; Li Ka Shing Institute of Health Sciences, and Department of Medicine & Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China.

Kidney International
|October 19, 2017
PubMed

Insights

Src activation drives kidney fibrosis through macrophage-myofibroblast transition. Targeting Src may offer a precision therapy for fibrotic diseases by inhibiting this pathway.

Area of Science:

  • Cell Biology
  • Renal Physiology
  • Molecular Medicine

Background:

  • Src activation is linked to kidney fibrogenesis.
  • Macrophage-to-myofibroblast transition (MMT) generates collagen-producing cells in fibrotic kidneys via TGF-β/Smad3.
  • The role of MMT in Src-mediated renal fibrosis remains unclear.

Purpose of the Study:

  • To investigate the role of MMT in Src-mediated renal fibrosis.
  • To identify the regulatory mechanisms underlying MMT.
  • To explore Src as a therapeutic target for MMT-driven fibrotic diseases.

Main Methods:

  • Single-cell RNA sequencing to identify differentially expressed genes during MMT.
  • In vivo studies using ureteral obstruction model.
  • In vitro studies using bone marrow-derived macrophages stimulated with TGF-β1.
  • Smad3 knockout models.

Main Results:

  • A Src-centric gene network regulating MMT was identified, with 501 differentially expressed genes.
  • Smad3 knockout reduced transcriptome diversity.
  • Src inhibition suppressed MMT in vivo and TGF-β1-induced MMT in vitro, including fibroblast-like morphology, α-smooth muscle actin expression, and collagen production.
  • Src is a direct Smad3 target gene and is upregulated in macrophages during MMT.

Conclusions:

  • MMT contributes to Src-mediated renal fibrosis.
  • Src acts as a key regulator in the MMT process.
  • Targeting Src presents a potential precision therapeutic strategy for fibrotic diseases driven by MMT.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
8.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.8K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
19.6K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.7K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.5K